I posted this early, but then asked the mods to remove it. But...

I posted this early, but then asked the mods to remove it. But I'll post it again:
................

I found yesterday's update a bit of a surprise.

Because before it was always stuff like "... shows improved and efficient healing" and "De-risked product with prior clinical experience demonstrated safety and efficacy" and "12 week data showed statistically significant wound area reduction from baseline" to it suddenly being "... how much of the healing was due to... "usual care"".

It has been stated again and again, as that one presentation alone clearly states (and there are heaps more), that efficacy has been demonstrated - clinically and statistically.

So when the trial results came out I thought it was as big a surprise and shock to the company as to me that the ftt treatment showed no difference at all.

But yesterday's update is now telling us that effectively no efficacy had been demonstrated against usual care and this was known hence "... this is the question that the Phase 2 trial (VF00102) was designed to answer", which in my interpretation is different to the guidance we have been given for years before.